Mankind Pharma Limited — Updates, 20-08-2026: Press Release
20-08-2026 | 01:37 pm
20-08-2026 | 01:37 pm
Mankind Pharma signed an exclusive in-licensing deal with Chongqing Chenan Biopharmaceutical for two insulin analogues in India. This strengthens its diabetes segment presence and expands its injectable diabetes portfolio.
No comments yet. Be the first to comment!
